Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Worswick

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Dermatologic Therapy|August 25, 2019
Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: A reviewVignesh Ravi, Nolan J Maloney, Scott Worswick
Dermatologic Therapy|December 30, 2016
Retinoic acid for treatment of systemic sclerosis and morphea: A literature reviewRenee M Thomas, Scott Worswick, Maria Aleshin
Dermatologic Clinics|August 31, 2019
Cutaneous Metastasis of Internal TumorsEvan Alexander Choate, Alexander Nobori, Scott Worswick
Dermatologic Therapy|March 6, 2019
Development of alopecia in patients treated with dupilumabNolan J Maloney, Scott Worswick, Kyle Cheng
International Journal of Dermatology|January 9, 2019
The role of biologics in the treatment of chronic granuloma annulareAlessandra Chen, Allison K Truong, Scott Worswick
Archives of Dermatology|December 21, 2011
Depigmented macules following autologous bone-marrow transplantScott Worswick, Aslan Pirouz, Delphine J Lee
Dermatology Online Journal|February 12, 2020
Verrucous venous malformationJoan Leavens, Scott Worswick, Gene H Kim
Cureus|June 2, 2023
Kaposi's Varicelliform Eruption After Treatment With Ixekizumab in a Patient With Pityriasis Rubra PilarisJana S Guenther, Iris Ahronowitz, Scott Worswick
Dermatologic Therapy|October 17, 2017
Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigationNolan J Maloney, Lisa D Hisaw, Scott Worswick
Journal of the American Academy of Dermatology|March 9, 2018
Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A reviewNolan J Maloney, Lisa D Hisaw, Scott Worswick
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Dermatologic Therapy|August 25, 2019
Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: A reviewVignesh Ravi, Nolan J Maloney, Scott Worswick
Dermatologic Therapy|December 30, 2016
Retinoic acid for treatment of systemic sclerosis and morphea: A literature reviewRenee M Thomas, Scott Worswick, Maria Aleshin
Dermatologic Clinics|August 31, 2019
Cutaneous Metastasis of Internal TumorsEvan Alexander Choate, Alexander Nobori, Scott Worswick
Dermatologic Therapy|March 6, 2019
Development of alopecia in patients treated with dupilumabNolan J Maloney, Scott Worswick, Kyle Cheng
International Journal of Dermatology|January 9, 2019
The role of biologics in the treatment of chronic granuloma annulareAlessandra Chen, Allison K Truong, Scott Worswick
Archives of Dermatology|December 21, 2011
Depigmented macules following autologous bone-marrow transplantScott Worswick, Aslan Pirouz, Delphine J Lee
Dermatology Online Journal|February 12, 2020
Verrucous venous malformationJoan Leavens, Scott Worswick, Gene H Kim
Cureus|June 2, 2023
Kaposi's Varicelliform Eruption After Treatment With Ixekizumab in a Patient With Pityriasis Rubra PilarisJana S Guenther, Iris Ahronowitz, Scott Worswick
Dermatologic Therapy|October 17, 2017
Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigationNolan J Maloney, Lisa D Hisaw, Scott Worswick
Journal of the American Academy of Dermatology|March 9, 2018
Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A reviewNolan J Maloney, Lisa D Hisaw, Scott Worswick
Pageof 9